Organon & Co (NYSE:OGN) currently has a daily average trading volume of 5.57M but it saw 6622287 shares traded in last market. With a market cap of 2.26B USD, the company’s current market price of $8.69 came rising about 3.08 while comparing to the previous closing price of $8.43. In past 52 weeks, the stock remained buoying in the range of price level as high as $23.10 and as low as $8.01.
JP Morgan downgraded its recommendation for the stock as a “Underweight” from “Neutral” on September 06, 2024 while assigning a price target range of $18-$20. Goldman also issued its recommendations for the stock as it downgraded the price target for the stock in the range of between $33 and $16.
Over the week, OGN’s stock price is moving -0.91% down while it is -24.37% when we observe its performance for the past one month. Year-to-date it is -41.76% down and over the past year, the stock is showing a downside performance of -60.08%.
Currently, Organon & Co’s total number of outstanding shares is 259.96M with 0.24% of that held by the insiders while 81.54% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at 7.91% and return on equity (ROE) at 254.24%. It has a price to earnings ratio (P/E ratio) of 3.01 while having a 2.13 of forward P/E ratio. Stock’s beta reads 0.57. Stock has a price to book (P/B) ratio of 4.14 while price to sale or P/S ratio amounts to 0.36. Its return on asset (ROA) is 5.99% on average.
